Display options
Share it on

Brain Tumor Res Treat. 2018 Apr;6(1):31-38. doi: 10.14791/btrt.2018.6.e5.

Mitochondrial 10398A>G NADH-Dehydrogenase Subunit 3 of Complex I Is Frequently Altered in Intra-Axial Brain Tumors in Malaysia.

Brain tumor research and treatment

Abdul Aziz Mohamed Yusoff, Fatin Najwa Zulfakhar, Siti Zulaikha Nashwa Mohd Khair, Wan Salihah Wan Abdullah, Jafri Malin Abdullah, Zamzuri Idris

Affiliations

  1. Department of Neurosciences, School of Medical Sciences, Universiti Sains Malaysia, Health Campus, Kelantan, Malaysia. [email protected].
  2. School of Health Sciences, Universiti Sains Malaysia, Health Campus, Kelantan, Malaysia.
  3. Department of Neurosciences, School of Medical Sciences, Universiti Sains Malaysia, Health Campus, Kelantan, Malaysia.
  4. Center for Neuroscience Services and Research, Universiti Sains Malaysia, Health Campus, Kelantan, Malaysia.

PMID: 29717568 PMCID: PMC5932297 DOI: 10.14791/btrt.2018.6.e5

Abstract

BACKGROUND: Mitochondria are major cellular sources of reactive oxygen species (ROS) generation which can induce mitochondrial DNA damage and lead to carcinogenesis. The mitochondrial 10398A>G alteration in NADH-dehydrogenase subunit 3 (ND3) can severely impair complex I, a key component of ROS production in the mitochondrial electron transport chain. Alteration in ND3 10398A>G has been reported to be linked with diverse neurodegenerative disorders and cancers. The aim of this study was to find out the association of mitochondrial ND3 10398A>G alteration in brain tumor of Malaysian patients.

METHODS: Brain tumor tissues and corresponding blood specimens were obtained from 45 patients. The ND3 10398A>G alteration at target codon 114 was detected using the PCR-RFLP analysis and later was confirmed by DNA sequencing.

RESULTS: Twenty-six (57.8%) patients showed ND3 10398A>G mutation in their tumor specimens, in which 26.9% of these mutations were heterozygous mutations. ND3 10398A>G mutation was not significantly correlated with age, gender, and histological tumor grade, however was found more frequently in intra-axial than in extra-axial tumors (62.5% vs. 46.2%, p<0.01).

CONCLUSION: For the first time, we have been able to describe the occurrence of ND3 10398A>G mutations in a Malaysian brain tumor population. It can be concluded that mitochondrial ND3 10398A>G alteration is frequently present in brain tumors among Malaysian population and it shows an impact on the intra-axial tumors.

Copyright © 2018 The Korean Brain Tumor Society, The Korean Society for Neuro-Oncology, and The Korean Society for Pediatric Neuro-Oncology.

Keywords: Brain tumor; Malaysia; Mitochondrial DNA; ND3 A10398G mutation

Conflict of interest statement

The authors have no financial conflicts of interest.

References

  1. Methods Mol Biol. 2009;471:291-303 - PubMed
  2. Malays J Med Sci. 2012 Jan;19(1):36-42 - PubMed
  3. Mol Med Rep. 2012 Nov;6(5):923-30 - PubMed
  4. Biomed Res Int. 2014;2014:540236 - PubMed
  5. Expert Rev Mol Med. 2002 Apr 11;4(9):1-19 - PubMed
  6. Asian Pac J Cancer Prev. ;17 (12 ):5195-5201 - PubMed
  7. Respir Med. 2013 Jun;107(6):911-8 - PubMed
  8. Genet Mol Res. 2015 Dec 21;14 (4):17426-31 - PubMed
  9. Oncol Lett. 2017 Nov;14 (5):5179-5188 - PubMed
  10. Med J Malaysia. 2014 Dec;69(6):261-7 - PubMed
  11. Exp Biol Med (Maywood). 2016 Jun;241(12 ):1281-95 - PubMed
  12. Ann Med. 2005;37(3):222-32 - PubMed
  13. Mitochondrial DNA. 2015 Feb;26(1):56-60 - PubMed
  14. World J Gastroenterol. 2014 Apr 14;20(14):3950-9 - PubMed
  15. Cancer Sci. 2014 Jun;105(6):639-45 - PubMed
  16. J Hum Genet. 2009 Nov;54(11):647-54 - PubMed
  17. Am J Hum Genet. 2003 Apr;72 (4):804-11 - PubMed
  18. Cancer Lett. 2007 May 8;249(2):249-55 - PubMed
  19. Acta Neuropathol. 2007 Aug;114(2):97-109 - PubMed
  20. Lancet. 2012 May 12;379(9828):1825-34 - PubMed
  21. Int J Mol Med. 2014 Jan;33(1):77-82 - PubMed
  22. Cancer Res. 2006 Feb 1;66(3):1880; author reply 1880-1 - PubMed
  23. Neurosci Lett. 2004 Jul 15;365(1):28-32 - PubMed
  24. Annu Rev Pathol. 2010;5:297-348 - PubMed
  25. Annu Rev Biochem. 1992;61:1175-212 - PubMed
  26. Cancer Res. 2005 Sep 1;65(17):8028-33 - PubMed
  27. Biomed Res Int. 2013;2013:612369 - PubMed
  28. Mitochondrion. 2004 Sep;4(5-6):755-62 - PubMed
  29. Neurogenetics. 1998 Mar;1(3):197-204 - PubMed
  30. Oncogene. 2000 Apr 13;19(16):2060-6 - PubMed
  31. Cancer Prev Res (Phila). 2011 May;4(5):638-54 - PubMed
  32. World J Gastroenterol. 2013 Dec 21;19(47):8880-6 - PubMed
  33. Lancet Oncol. 2014 Aug;15(9):e395-403 - PubMed
  34. Genomics. 1993 Jul;17(1):171-84 - PubMed
  35. Nat Rev Mol Cell Biol. 2012 Dec;13(12):780-8 - PubMed
  36. Neuro Oncol. 2015 Jun;17(6):776-83 - PubMed
  37. Breast Cancer Res Treat. 2010 Jun;121(2):511-8 - PubMed
  38. Cancer Res. 2007 May 15;67(10):4687-94 - PubMed
  39. Oncogene. 2006 Aug 7;25(34):4663-74 - PubMed
  40. Genes Chromosomes Cancer. 2011 Oct;50(10):800-11 - PubMed
  41. Biochim Biophys Acta. 2011 Jun;1807(6):620-5 - PubMed
  42. Cancer Genet Cytogenet. 2008 Feb;181(1):16-9 - PubMed

Publication Types